GLP-1 drugs like Ozempic and Wegovy have revolutionized diabetes and weight management, but rising reports of severe side effects, including gastroparesis, are sparking lawsuits and calls for deeper research. While millions benefit from these treatments, patients and experts alike are raising concerns about long-term risks, inadequate warnings, and gaps in healthcare communication. With questions lingering about potential lasting complications, the need for independent studies and better patient education has never been more urgent.
Patients Are Suing Over Alleged Side Effects of Weight-Loss Drugs (TIME)
0